Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 109Leukemia, Myeloid, Acute 102Leukemia 97Myelodysplastic Syndromes 87Precursor Cell Lymphoblastic Leukemia-Lymphoma 74Lymphoma, Non-Hodgkin 71Lymphoma 71Multiple Myeloma 70Hodgkin Disease 68Lymphoma, Mantle-Cell 53Lymphoma, Follicular 51Lymphoma, Large B-Cell, Diffuse 50Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Lymphoma, B-Cell, Marginal Zone 44Myeloproliferative Disorders 43Congenital Abnormalities 41Burkitt Lymphoma 37Leukemia, Myelomonocytic, Chronic 36Waldenstrom Macroglobulinemia 32Leukemia, Myeloid, Accelerated Phase 32Primary Myelofibrosis 31Melanoma 31Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic-Phase 31Blast Crisis 28Recurrence 27Neoplasms, Plasma Cell 25Hematologic Neoplasms 24Lymphoma, T-Cell, Cutaneous 23Dendritic Cell Sarcoma, Interdigitating 23

Interventions

Paclitaxel 2Carboplatin 2fludarabine phosphate 1fludarabine 1figitumumab 1aldesleukin 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Interleukin-2 1Cyclophosphamide 1Chemoradiotherapy 1Cetuximab 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Adenosquamous × fludarabine phosphate × Clear all
NCT03215810 2023-07-24

Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
20 enrolled 10 charts
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Recurrence, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡